Modulation of higher-primate adrenal androgen secretion with estrogen-alone or estrogen-plus-progesterone intervention

Menopause

Volumn 20, Issue 3, 2013, Pages 322-328

  Conley, Alan J ^a   Stanczyk, Frank Z ^b   Morrison, John H ^c   Borowicz, Pawel ^d   Benirschke, Kurt ^e   Gee, Nancy A ^a,f   Lasley, Bill L ^a,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d NORTH DAKOTA STATE UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adrenal; Hormone therapy; Replacement; Steroids

Indexed keywords

ANDROSTENEDIOL; ANDROSTENEDIONE; ESTROGEN; PRASTERONE; PRASTERONE SULFATE; PROGESTERONE; TESTOSTERONE;

ADRENAL CORTEX; ANDROGEN BLOOD LEVEL; ANDROGEN RELEASE; ANDROSTENEDIONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HORMONAL THERAPY; NONHUMAN; OVARIECTOMY; STATISTICAL SIGNIFICANCE; TESTOSTERONE BLOOD LEVEL;

EID: 85027917527     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0b013e318273a070     Document Type: Article

References (55)

1. Lasley BL, Santoro N, Randolf JF, et al. The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity. J Clin Endocrinol Metab 2002;87: 3760-3767.
2. Crawford S, Santoro N, Laughlin GA, et al. Circulating dehydroepiandrosterone sulfate concentrations during the menopausal transition. J Clin Endocrinol Metab 2009;94: 2945-2951.
3. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 2001;76: 874-878.
4. Prior JC. Perimenopause: the complex endocrinology of the menopausal transition. Endocr Rev 1998;19: 397-428.
5. Skurnick JH, Weiss G, Goldsmith LT, Santoro N, Crawford S. Longitudinal changes in hypothalamic and ovarian function in perimenopausal women with anovulatory cycles: relationship with vasomotor symptoms. Fertil Steril 2009;91: 1127-1134.
6. The North American Menopause Society Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 2004;11: 11-33.
7. Rapkin AJ. Vasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatment. Am J Obstet Gynecol 2007;196: 97-106.
8. Burger HG, Dudley EC, Robertson DM, Dennerstein L. Hormonal changes in the menopause transition. Recent Prog Horm Res 2002;57: 257-275.
9. The North American Menopause Society Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause 2010;17: 242-255.
10. Davis SR, Panjari M, Stanczyk FZ. Clinical review: DHEA replacement for postmenopausal women. J Clin Endocrinol Metab 2011;96: 1642-1653.
11. McConnell DS, Stanczyk FZ, Sowers MR, Randolph JF Jr, Lasley BL. Menopausal transition stage-specific changes in circulating adrenal androgens. Menopause 2012;19: 658-663.
12. Lasley BL, Chen J, Stanczyk FZ, et al. Androstenediol complements estrogenic bioactivity during the menopausal transition. Menopause 2012;19: 650-657.
13. Hodgen GD, Goodman AL, O'Connor A, Johnson DK. Menopause in rhesus monkeys: model for study of disorders in the human climacteric. Am J Obstet Gynecol 1977;127: 581-584.
14. Walker ML. Menopause in female rhesus-monkeys. Am J Primatol 1995;35: 59-71.
15. Johnson RL, Kapsalis E. Menopause in free-ranging rhesus macaques: estimated incidence, relation to body condition, and adaptive significance. Int J Primatol 1998;19: 751-765.
16. Walker ML, Herndon JG. Menopause in nonhuman primates? Biol Reprod 2008;79: 398-406.
17. Mesiano S, Jaffe RB. Developmental and functional biology of the primate fetal adrenal cortex. Endocr Rev 1997;18: 378-403.
18. Conley AJ, Pattison JC, Bird IM. Variations in adrenal androgen production among (nonhuman) primates. Semin Reprod Med 2004;22: 311-326.
19. Nguyen AD, Conley AJ. Adrenal androgens in humans and nonhuman primates: production, zonation and regulation. Endocr Dev 2008;13: 33-54.
20. Nguyen AD, Corbin CJ, Pattison JC, Bird IM, Conley AJ. The developmental increase in adrenocortical 17,20-lyase activity (biochemical adrenarche) is driven primarily by increasing cytochrome b5 in neonatal rhesus macaques. Endocrinology 2009;150: 1748-1756.
21. Nguyen AD, Mapes SM, Corbin CJ, Conley AJ. Morphological adrenarche in rhesus macaques: development of the zona reticularis is concurrent with fetal zone regression in the early neonatal period. J Endocrinol 2008;199: 367-378.
22. Conley AJ, Plant TM, Abbott DH, Moeller BC, Stanley SD. Adrenal androgen concentrations increase during infancy in male rhesus macaques (Macaca mulatta). Am J Physiol Endocrinol Metab 2011;301: 1229-1235.
23. Goncharova ND, Lapin BA. Effects of aging on hypothalamic- pituitaryadrenal system function in non-human primates. Mech Ageing Dev 2002; 123: 1191-1201.
24. Goncharova ND, Lapin BA. Age-related endocrine dysfunction in nonhuman primates. Ann N Y Acad Sci 2004;1019: 321-325.
25. Shideler SE, Gee NA, Chen J, Lasley BL. Estrogen and progesterone metabolites and follicle-stimulating hormone in the aged macaque female. Biol Reprod 2001;65: 1718-1725.
26. Bulbrook RD, Herian M, Tong D, Hayward JL, Swain MC, Wang DY. Effect of steroidal contraceptives on levels of plasma androgen sulphates and cortisol. Lancet 1973;1: 628-631.
27. Rance TA, Park BK. Effect of an oral contraceptive on plasma dehydroepiandrosterone concentrations. Experientia 1977;33: 1239-1240.
28. Madden JD, Milewich L, Parker CR Jr, Carr BR, Boyar RM, Mac Donald PC. The effect of oral contraceptive treatment on the serum concentration of dehydroisoandrosterone sulfate. Am J Obstet Gynecol 1978;132: 380-384.
29. Tazuke S, Khaw KT, Barrett-Connor E. Exogenous estrogen and endogenous sex hormones. Medicine (Baltimore) 1992;71: 44-51.
30. Wiegratz I, Jung-Hoffmann C, Kuhl H. Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins. Contraception 1995; 51: 341-346.
31. Casson PR, ElkindHirsch KE, Buster JE, Hornsby PJ, Carson SA, Snabes MC. Effect of postmenopausal estrogen replacement on circulating androgens. Obstet Gynecol 1997;90: 995-998.
32. Aden U, Jung-Hoffmann C, Kuhl H. A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives. Contraception 1998;58: 75-81.
33. Carlstrom K, Karlsson R, Von SB. Diurnal rhythm and effects of oral contraceptives on serum dehydroepiandrosterone sulfate (DHEAS) are related to alterations in serum albumin rather than to changes in adrenocortical steroid secretion. Scand J Clin Lab Invest 2002;62: 361-368.
34. Nader S, Diamanti-Kandarakis E. Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis. Hum Reprod 2007;22: 317-322.
35. Yildiz BO. Oral contraceptives in polycystic ovary syndrome: risk-benefit assessment. Semin Reprod Med 2008;26: 111-120.
36. Rapp PR, Morrison JH, Roberts JA. Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys. J Neurosci 2003;23: 5708-5714.
37. Koritnik DR, Laherty RF, Rotten D, Jaffe RB. A radioimmunoassay for dehydroepiandrosterone sulfate in the circulation of rhesus monkeys. Steroids 1983;42: 653-667.
38. Lane MA, Ingram DK, Ball SS, Roth GS. Dehydroepiandrosterone sulfate: a biomarker of primate aging slowed by calorie restriction. J Clin Endocrinol Metab 1997;82: 2093-2096.
39. Goncharova ND, Oganyan TE, Taranov AG. Functions of the hypothalamohypophyseal- adrenal system in aging in female monkeys. Neurosci Behav Physiol 2000;30: 717-721.
40. Parker CR Jr, Mixon RL, Brissie RM, Grizzle WE. Aging alters zonation in the adrenal cortex of men. J Clin Endocrinol Metab 1997;82: 3898-3901.
41. Dharia S, Slane A, Jian M, et al. Effects of aging on cytochrome b5 expression in the human adrenal gland. J Clin Endocrinol Metab 2005; 90: 4357-4361.
42. Sulcova J, Hill M, Hampl R, Starka L. Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects. J Endocrinol 1997;154: 57-62.
43. Sandoval-Guzman T, Stalcup ST, Krajewski SJ, Voytko ML, Rance NE. Effects of ovariectomy on the neuroendocrine axes regulating reproduction and energy balance in young cynomolgus macaques. J Neuroendocrinol 2004;16: 146-153.
44. Rose DP, Fern M, Liskowski L, Milbrath Jr. Effect of treatment with estrogen conjugates on endogenous plasma steroids. Obstet Gynecol 1977;49: 80-82.
45. Lobo RA, Goebelsmann U, Brenner PF, Mishell DR Jr. The effects of estrogen on adrenal androgens in oophorectomized women. Am J Obstet Gynecol 1982;142: 471-478.
46. Slayden SM, Crabbe L, Bae S, Potter HD, Azziz R, Parker CR Jr. The effect of 17A-estradiol on adrenocortical sensitivity, responsiveness, and steroidogenesis in postmenopausal women. J Clin Endocrinol Metab 1998;83: 519-524.
47. Lasley BL, Crawford SL, Laughlin GA, et al. Circulating dehydroepiandrosterone sulfate levels in women who underwent bilateral salpingooophorectomy during the menopausal transition. Menopause 2011;18: 494-498.
48. Adams J, Garcia M, Rochefort H. Estrogenic effects of physiological concentrations of 5-androstene-3A,17A-diol and its metabolism in MCF7 human breast cancer cells. Cancer Res 1981;41: 4720-4726.
49. Cizza G, Ronsaville DS, Kleitz H, et al. Clinical subtypes of depression are associated with specific metabolic parameters and circadian endocrine profiles in women: the power study. PLoS One 2012;7: e28912.
50. Tan XJ, Dai YB, Wu WF, et al. Reduction of dendritic spines and elevation of GABAergic signaling in the brains of mice treated with an estrogen receptor A ligand. Proc Natl Acad Sci U S A 2012;109: 1708-1712.
51. Su IH, Chen Y-C, Hwang W-T, et al. Risks and benefits of menopausal hormone therapy in postmenopausal Chinese women.Menopause 2012;19: 931-941.
52. Honma N, Horii R, Iwase T, et al. Clinical importance of androgen receptor in breast cancer patients treated with adjuvant tamoxifen monotherapy. Breast Cancer 2012;10: 1848-1854.
53. Chlebowski RT, Anderson GL, Gass M, et al. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA 2010;304: 1684-1692.
54. Burger HG, Hale GE, Dennerstein L, Robertson DM. Cycle and hormone changes during perimenopause: the key role of ovarian function. Menopause 2008;15: 603-612.
55. Fitzgerald CT, Seif MW, Killick SR, Elstein M. Age related changes in the female reproductive cycle. Br J Obstet Gynaecol 1994;101: 229-233.